Bush Lelie, H. L., Liba,A., Bourassa, M.W., Chattopadhyay, M., Chan, P. K., Gralla, E. B., Miller, L. M., Borchelt, D. R., Valentine, J. S., and Whitelegge, J. P. (2011). Copper and zinc metallation status of copper-zinc superoxide dismutase from ALS-transgenic mice. J. Biol. Chem. 286, 2795–2806. Liu, H., Zhu, H., Eggers, D. K., Nersissian, A. M., Faull, K. F., Goto, J. J., Ai, J., Sanders-Loehr, J., Gralla, E. B., and Valentine, J. S. (2000). Copper(2+) binding to the sur- face residue cysteine 111 of His46Arg human copper- zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry 39, 8125–8132. Nagano, S., Fujii,Y.,Yamamoto, T., Taniyama, M., Fukada, K.,Yanagihara, T., and Sakoda, S. (2003). The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice. Exp. Neurol. 179, 176–180. Nagano, S., Ogawa, Y., Yanagihara, T., and Sakoda, S. (1999). Benefit of a combined treatment with tri- entine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci. Lett. 265, 159–162. Son,M.,Puttaparthi,K.,Kawamata,H.,Rajendran,B.,Boyer, P.J.,Manfredi,G.,andElliott,J.L.(2007).Overexpression Pathological copper site on SOD1 of CCS in G93A-SOD1 mice leads to accelerated neu- rological deficits with severe mitochondrial pathology. Proc. Natl. Acad. Sci. U.S.A. 104, 6072–6077. Subramaniam, J. R., Lyons, W. E., Liu, J., Bartnikas, T. B., Rothstein, J., Price, D. L., Cleveland, D. W., Gitlin, J. D., and Wong, P. C. (2002). Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301–307. Tiwari, A., and Hayward, L. J. (2003). Familial amyo- trophic lateral sclerosis mutants of copper/zinc super- oxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 278, 5984–5992. Tokuda, E., Ono, S., Ishige, K., Watanabe, S., Okawa, E., Ito, Y., and Suzuki, T. (2008). Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exp. Neurol. 213, 122–128. Watanabe, S., Nagano, S., Duce, J., Kiaei, M., Li, Q. X., Tucker, S. M., Tiwari, A., Brown, R. H. Jr., Beal, M. F., Hayward, L. J., Culotta,V. C.,Yoshihara, S., Sakoda, S., and Bush, A. I. (2007). Increased affinity for copper mediated by cysteine 111 in forms of mutant superox- ide dismutase 1 linked to amyotrophic lateral sclerosis. Free Radic. Biol. Med. 42, 1534–1542. Zhang, Q., and Kelly, J.W. (2003). Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 42, 8756–8761. Zhang, Q., and Kelly, J.W. (2005). Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? Biochemistry 44, 9079–9085. Received: 14 May 2011; accepted: 20 July 2011; published online: 11 August 2011. Citation: Bush AI (2011) A copper binding site within the pathological conformer epitope of mutant SOD1. Front. Neurosci. 5:97. doi: 10.3389/fnins.2011.00097 This article was submitted to Frontiers in Neurodegeneration, a specialty of Frontiers in Neuroscience. Copyright © 2011 Bush. This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with. Frontiers in Neuroscience | Neurodegeneration August 2011 | Volume 5 | Article 97 | 2